# Low-Intensity Focused Ultrasound Neuromodulation of the Mediodorsal Thalamus for Treatment-Resistant Schizophrenia

> **NCT05259306** · NA · SUSPENDED · sponsor: **NYU Langone Health** · enrollment: 3 (estimated)

## Conditions studied

- Treatment-resistant Schizophrenia

## Interventions

- **DEVICE:** Insightec Exablate Neuro MR-guided focused ultrasound transducer

## Key facts

- **NCT ID:** NCT05259306
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2027-06
- **Primary completion:** 2028-06
- **Final completion:** 2029-06
- **Target enrollment:** 3 (ESTIMATED)
- **Why stopped:** Indefinite hold due to administrative issues.
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05259306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05259306, "Low-Intensity Focused Ultrasound Neuromodulation of the Mediodorsal Thalamus for Treatment-Resistant Schizophrenia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05259306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*